AUPH
NASDAQ · Biotechnology
Aurinia Pharmaceuticals Inc
$17.36
-0.17 (-0.97%)
Open$17.42
Previous Close$17.53
Day High$17.77
Day Low$17.32
52W High$16.88
52W Low$7.29
Volume—
Avg Volume1.01M
Market Cap2.12B
P/E Ratio7.10
EPS$2.17
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+134.1% upside
Current
$17.36
$17.36
Target
$40.64
$40.64
$34.07
$40.64 avg
$61.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 265.03M | 206.55M | 554.79M |
| Net Income | 268.91M | 188.62M | -143,878,553 |
| Profit Margin | 101.5% | 96.4% | -25.9% |
| EBITDA | 116.44M | 86.21M | -183,212,536 |
| Free Cash Flow | — | — | -112,933,113 |
| Rev Growth | +28.3% | +28.3% | +6.7% |
| Debt/Equity | 0.12 | 0.12 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |